Kirsten Mascioli

The pharmacological chaperone 1-deoxynojirimycin increases the activity and lysosomal trafficking of multiple mutant forms of acid alpha-glucosidase

John J. Flanagan, Barbara Rossi, Katherine C. Tang et al. · Human Mutation · 2009 · 93 citations

Life Sciences, Biochemistry, Pharmacology +17

A pharmacogenetic approach to identify mutant forms of α‐galactosidase a that respond to a pharmacological chaperone for Fabry disease

Xiaoyang Wu, Evan Katz, Maria Cecilia Della Valle et al. · Human Mutation · 2011 · 85 citations · Full text

Life Sciences, Biochemistry, Pharmacology +13

Multi-focal control of mitochondrial gene expression by oncogenic MYC provides potential therapeutic targets in cancer

Amanda R. Oran, Clare M. Adams, Xiao-yong Zhang et al. · Oncotarget · 2016 · 53 citations · Full text

Medicine, Cancer Biology, Oncology +16

Inhibition of pro-inflammatory cytokine generation by CTLA4-Ig in the skin and colon of mice adoptively transplanted with CD45RBhi CD4+ T cells correlates with suppression of psoriasis and colitis

Colleen Davenport, Holly Ann McAdams, Jen P. Kou et al. · International Immunopharmacology · 2002 · 31 citations

Life Sciences, Dermatology, Immunology +14